OBJECTIVE: To describe the indications for breast magnetic resonance imaging (MRI) at a referral center for breast cancer in Brazil. MATERIALS AND METHODS: This was a retrospective study in which we reviewed the clinical records, including physician requests and patient questionnaires, of women who underwent breast MRI between 2014 and 2018 at a referral center for the diagnosis and treatment of breast cancer in the city of Belo Horizonte, Brazil. RESULTS: The most common indication for breast MRI was as a complement to mammography/ultrasonography (in 43.6% of cases), followed by breast cancer staging (in 25.1%), the screening of patients at high risk (in 17.4%), the evaluation of breast implants (in 10.1%), and the evaluation of the response to neoadjuvant chemotherapy (in 3.8%). CONCLUSION: Although there is strong evidence supporting the use of breast MRI, mainly for the screening of high-risk patients, the imaging method is underutilized in Brazil.
OBJECTIVE: To describe the indications for breast magnetic resonance imaging (MRI) at a referral center for breast cancer in Brazil. MATERIALS AND METHODS: This was a retrospective study in which we reviewed the clinical records, including physician requests and patient questionnaires, of women who underwent breast MRI between 2014 and 2018 at a referral center for the diagnosis and treatment of breast cancer in the city of Belo Horizonte, Brazil. RESULTS: The most common indication for breast MRI was as a complement to mammography/ultrasonography (in 43.6% of cases), followed by breast cancer staging (in 25.1%), the screening of patients at high risk (in 17.4%), the evaluation of breast implants (in 10.1%), and the evaluation of the response to neoadjuvant chemotherapy (in 3.8%). CONCLUSION: Although there is strong evidence supporting the use of breast MRI, mainly for the screening of high-risk patients, the imaging method is underutilized in Brazil.
Entities:
Keywords:
Breast neoplasms/diagnostic imaging; Early detection of cancer/methods; Magnetic resonance imaging
Authors: Debbie Saslow; Carla Boetes; Wylie Burke; Steven Harms; Martin O Leach; Constance D Lehman; Elizabeth Morris; Etta Pisano; Mitchell Schnall; Stephen Sener; Robert A Smith; Ellen Warner; Martin Yaffe; Kimberly S Andrews; Christy A Russell Journal: CA Cancer J Clin Date: 2007 Mar-Apr Impact factor: 508.702
Authors: Janice S Sung; Jie Li; Glenys Da Costa; Sujata Patil; Kimberly J Van Zee; D David Dershaw; Elizabeth A Morris Journal: AJR Am J Roentgenol Date: 2014-06 Impact factor: 3.959
Authors: Linda Moy; Kristin Elias; Vashali Patel; Jiyon Lee; James S Babb; Hildegard K Toth; Cecilia L Mercado Journal: AJR Am J Roentgenol Date: 2009-10 Impact factor: 3.959
Authors: Kevin C Oeffinger; Elizabeth T H Fontham; Ruth Etzioni; Abbe Herzig; James S Michaelson; Ya-Chen Tina Shih; Louise C Walter; Timothy R Church; Christopher R Flowers; Samuel J LaMonte; Andrew M D Wolf; Carol DeSantis; Joannie Lortet-Tieulent; Kimberly Andrews; Deana Manassaram-Baptiste; Debbie Saslow; Robert A Smith; Otis W Brawley; Richard Wender Journal: JAMA Date: 2015-10-20 Impact factor: 56.272
Authors: Karen J Wernli; Wendy B DeMartini; Laura Ichikawa; Constance D Lehman; Tracy Onega; Karla Kerlikowske; Louise M Henderson; Berta M Geller; Mike Hofmann; Bonnie C Yankaskas Journal: JAMA Intern Med Date: 2014-01 Impact factor: 21.873
Authors: László Tabár; Peter B Dean; Tony Hsiu-Hsi Chen; Amy Ming-Fang Yen; Sam Li-Sheng Chen; Jean Ching-Yuan Fann; Sherry Yueh-Hsia Chiu; May Mei-Sheng Ku; Wendy Yi-Ying Wu; Chen-Yang Hsu; Yu-Ching Chen; Kerri Beckmann; Robert A Smith; Stephen W Duffy Journal: Cancer Date: 2018-11-08 Impact factor: 6.860